Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Quantitative Determination of HSP60: Technical Methods and Clinical Applications

HSP60 quantitative determination is a critical laboratory procedure used to measure the concentration of Heat Shock Protein 60 in biological samples. This analysis plays a vital role in researching cellular stress responses, autoimmune diseases, and various cancer biomarkers. By utilizing advanced immunoassay techniques, researchers can obtain accurate data for clinical diagnostics and biomedical studies.

HSP60

Technical Overview

HSP60, also known as Heat Shock Protein 60, is a mitochondrial chaperonin essential for protein folding and the cellular stress response. Quantitative determination of HSP60 involves measuring the specific concentration of this protein within various biological matrices. This process is fundamental for understanding the pathogenesis of numerous diseases, as aberrant expression of HSP60 is linked to autoimmune disorders, cancer progression, and cardiovascular diseases. The assay relies heavily on the specific binding between the HSP60 antigen and its corresponding high-affinity antibody.

Testing Samples

The selection and preparation of samples are critical for the accuracy of HSP60 quantitative determination. Different sample types require specific handling protocols to ensure protein integrity.

Serum and Plasma

Blood samples are the most common matrices for clinical HSP60 testing. Serum is obtained by allowing blood to clot, while plasma requires anticoagulants such as heparin or EDTA. Samples should be centrifuged promptly to remove cellular debris and stored at low temperatures to prevent protein degradation.

Cell Lysates and Culture Supernatants

For in vitro studies, researchers often quantify HSP60 in cell culture supernatants or cell lysates. Lysates require lysis buffers containing protease inhibitors to preserve protein integrity during the extraction process. Supernatants are typically collected after centrifugation to remove cells and debris.

Tissue Homogenates

Tissue samples from biopsies or animal models are homogenized in specific buffers to release intracellular HSP60. The homogenate is then centrifuged, and the supernatant is used for quantitative analysis to determine tissue-specific expression levels.

Testing Items

The primary testing item is the quantitative concentration of the HSP60 protein, typically expressed in units such as ng/mL or pg/mL. The assay specifically detects the target protein independent of other heat shock proteins. In some advanced testing panels, the determination may include the ratio of HSP60 to other biomarkers to provide a more comprehensive clinical profile.

Testing Methods

Several established methodologies are employed for the quantitative determination of HSP60, with Enzyme-Linked Immunosorbent Assay (ELISA) being the most prevalent.

  • ELISA: This is the standard method due to its high sensitivity and specificity. Sandwich ELISA is commonly used, where a capture antibody binds HSP60, and a detection antibody provides a signal proportional to the concentration.
  • Western Blotting: While traditionally semi-quantitative, modern quantitative Western Blotting uses known standards and fluorescence detection to calculate absolute protein amounts.
  • Luminex xMAP Technology: This multiplex assay allows for the simultaneous quantification of HSP60 along with other cytokines, saving sample volume and time.

Applications

The quantitative measurement of HSP60 has significant implications in both clinical diagnostics and fundamental biological research.

  • Autoimmune Diseases: Elevated HSP60 levels are often observed in patients with rheumatoid arthritis and systemic lupus erythematosus, serving as a potential diagnostic or prognostic marker.
  • Oncology: HSP60 expression is frequently upregulated in various tumors. Quantitative determination helps in monitoring tumor progression and evaluating the efficacy of therapeutic agents targeting the chaperone system.
  • Cardiovascular Health: HSP60 acts as a danger signal when released into the extracellular space during cardiac stress, making it a valuable biomarker for atherosclerosis and heart failure.

FAQ

What is the typical sensitivity range of HSP60 ELISA kits?

Most commercial ELISA kits for HSP60 quantitative determination offer a sensitivity range between 0.1 ng/mL and 10 ng/mL, though this can vary by manufacturer.

How should samples be stored before testing?

Samples should ideally be processed immediately. If immediate testing is not possible, serum or plasma should be aliquoted and stored at -20 degrees Celsius or -80 degrees Celsius to avoid freeze-thaw cycles which can degrade the protein.

Is fasting required for blood sample collection?

Fasting is generally not strictly required for HSP60 determination, but it is recommended to follow specific study protocols or kit instructions to minimize interference from lipids or other serum components.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing